Product Information
MOXIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.5963 per ML under NDC 00832141003. Its NADAC has been published 269 times since Aug 11, 2021.
FDA first approved this application on Feb 10, 2021. Its Orange Book therapeutic-equivalence code is AT1.
Strength
5 mg/mL
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832141003
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212616FDA Approved
2/10/2021
TE Code
AT1
On Market Since
2/10/2021
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROPS has been published 269 times since Aug 11, 2021, and over the history we have for it it has declined 72.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5963 per ML |
|---|---|
| All-time high | $5.7142 (Aug 11, 2021) |
| All-time low | $1.5386 (Aug 19, 2026) |
| 52-week high | $1.8460 |
| 52-week low | $1.5386 |
| Median price | $2.5520 |
| Average price | $2.8520 |
| Largest weekly change | +41.1% (Nov 23, 2022) |
| Weeks tracked | 269 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Moxifloxacin Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Moxifloxacin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROPS, manufactured by Upsher-Smith Laboratories LLC, is $1.5963 per ML (NDC 00832141003), effective Sep 30, 2026.
How has the price of MOXIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has declined 72.1%. It has been tracked across 269 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROPS?
Since Aug 11, 2021, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has ranged from a low of $1.5386 (Aug 19, 2026) to a high of $5.7142 (Aug 11, 2021), with a median of $2.5520 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of MOXIFLOXACIN 0.5% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MOXIFLOXACIN 0.5% EYE DROPS?
MOXIFLOXACIN 0.5% EYE DROPS (NDC 00832141003) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.